21525 ⎘
Preparations containing radioactive substances for use in therapy or testing characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus; Organic compounds; Lipids, e.g. triglycerides; Polycationic carriers Amines, polyamines, e.g. spermine, spermidine, amino acids, (bis)guanidines
DUAL MODE RADIOTRACER AND -THERAPEUTICS
#2PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS WITH IMPROVED RENAL CLEARANCE
#3PSMA binding dual mode radiotracer and therapeutics
#4METHODS FOR TREATING PROSTATE CANCER WITH RADIOPHARMACEUTICALS
#5TARGETED RADIOTHERANOSTICS BASED ON POLYAZAMACROCYCLIC, MIXED-DONOR SCAFFOLDS LINKED TO A TARGETING VECTOR
#6RADIOLABELED COMPOUNDS TARGETING THE PROSTATE-SPECIFIC MEMBRANE ANTIGEN
#7COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS
#8RADIOPHARMACEUTICAL AND METHODS
#9LABELED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA), THEIR USE AS IMAGING AGENTS AND PHARMACEUTICAL AGENTS FOR THE TREATMENT OF PSMA-EXPRESSING CANCERS
#10Oxidative Cyclization Reagents for Chemoselective Tryptophan Bioconjugation
#11HEPTAMETHINE CARBOCYANINE DYE-DOTA CONJUGATES COMPLEXED WITH LUTETIUM-177, YTTRIUM-90, OR GALLIUM-68, AND THEIR USES FOR IMAGE-GUIDED RADIOTHERAPY
#12CANCER THERANOSTIC COMPOSITIONS COMPRISING BIGUANIDE COMPLEXES OF GROUP 7 TRANSITION METALS AND USES THEREOF
#13BISPIDINE DERIVATIVES AND THE USE THEREOF
#14PREPARATIONS OF META-IODOBENZYLGUANIDINE AND PRECURSORS THEREOF
#15IMAGING OF MYELOMA BONE LESIONS
#16PSMA TARGETING UREA-BASED LIGANDS FOR PROSTATE CANCER RADIOTHERAPY AND IMAGING
#17IMAGING OF BRAIN LESIONS
#18ELUENT SOLUTION
#19PREPARATIONS OF META-IODOBENZYLGUANIDINE AND PRECURSORS THEREOF
#20PHARMACEUTICAL COMPOSITION CONTAINING 211AT-LABELED AMINO ACID DERIVATIVE, AND METHOD FOR PRODUCING SAID PHARMACEUTICAL COMPOSITION
#21OLIGONUCLEOTIDE CONJUGATE WITH HIGH HYBRIDIZATION PERFORMANCE AND USE THEREOF
#22Chelated PSMA Inhibitors
#23Compositions and methods to detect GLUA1 in brain and to identify the presence of GLUA1-mediated PTSD
#24ELUENT SOLUTION
#25PSMA BINDING DUAL MODE RADIOTRACER AND THERAPEUTIC
#26COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS
#27LABELED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA), THEIR USE AS IMAGING AGENTS AND PHARMACEUTICAL AGENTS FOR THE TREATMENT OF PSMA-EXPRESSING CANCERS
#28PRECURSOR COMPOUND OF RADIOACTIVE HALOGEN-LABELED ORGANIC COMPOUND
#29ACETYLATED PRODRUGS FOR DELIVERY ACROSS THE BLOOD-BRAIN BARRIER
#30Formulation and method of synthesis
#31PSMA-based molecular-genetic reporter system
#32RADIOPHARMACEUTICAL SYNTHESIS METHODS
#33Precursor compound of radioactive halogen-labeled organic compound
#34Combination of Deuterated Levodopa With Carbidopa and Opicapone For The Treatment of Parkinson's Disease
#35Preparations of meta-iodobenzylguanidine and precursors thereof
#36Double-labeled probe for molecular imaging and use thereof
#37Chelated PSMA inhibitors
#38F-labeled compounds for PET imaging and uses thereof
#3918F labeled amino acids, derivatives thereof and method of making same
#4018F-FLUCICLOVINE COMPOSITIONS IN CITRATE BUFFERS
#41Compositions and methods to detect GluA1 in brain and to identify the presence of GluA1-mediated PTSD
#42Reducing memory loss in mammals suffering from Alzheimer's disease
#43Precursor compound of radioactive halogen-labeled organic compound
#44Radiolabelling Process
#45Diagnostic imaging agent for early bone metastasis from cancer
#46Risk Stratification
#47Risk Stratification
#48Functionalized linear ligands and complexes thereof
#49Compositions, methods, and systems for the synthesis and use of imaging agents
#50PSMA-targeting imaging agents
#51PSMA-based molecular-genetic reporter system
#52Combination of Deuterated Levodopa With Carbidopa and Opicapone For The Treatment of Parkinson's Disease
#53FLUORINATED 2-AMINO-4-(BENZYLAMINO)PHENYLCARBAMATE DERIVATIVES
#54Compositions, methods, and systems for the synthesis and use of imaging agents
#55Reducing memory loss in mammals suffering from alzheimer's disease
#56Methods of synthesizing γ-aapeptides, γ-aapeptide building blocks, γ-aapeptide libraries, and γ-aapeptide inhibitors of Aβaggregates
#57Method for purification of 18F-labeled choline analogues
#58Precursor compound of radioactive halogen-labeled organic compound
#59Information processing apparatus that calculates index indicating probability of event occurring to patient in future
#60Detection of early-stage pancreatic adenocarcinoma
#61Information processing apparatus for calculating index for supporting diagnosis of subject
#62Radiolabelling process
#63Precursor compound of radioactive halogen-labeled organic compound
#64Antibodies reactive with an epitope located in the N-terminal region of MUC5AC comprising cysteine-rich subdomain 2 (Cys2)
#6518F-FLUCICLOVINE COMPOSITIONS IN CITRATE BUFFERS
#66PSMA-targeting imaging agents
#67Labeled molecular imaging agents and methods of use
#68Labeled molecular imaging agents and methods of use
#69Anti-mucin antibodies for early detection and treatment of pancreatic cancer
#70Dose synthesis card for use with automated biomarker production system
#71Double-labeled probe for molecular imaging and use thereof
#72Fluorinated 2-amino-4-(benzylamino)phenylcarbamate derivatives
#73N-alkoxyamide conjugates as imaging agents
#74Radiopharmaceutical synthesis methods
#75Automatic system for synthesizing I-MIBG and automatic device for synthesizing and dispensing I-MIBG comprising the same
#76Radiolabeled amino acids for diagnostic imaging
#77Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
#78Anti-mucin antibodies for early detection and treatment of pancreatic cancer
#79Method for the synthesis of 18F-labelled molecules
#80Method for the synthesis of F-labelled biomolecules
#81Anti-mucin antibodies for early detection and treatment of pancreatic cancer
#82Precursor compound of radioactive halogen-labeled organic compound
#8318F-labeled precursor of PET radioactive medical supplies, and preparation method thereof
#84Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof
#85In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agents
#86Precursor compound connected to solid support for manufacturing 18F radiopharmaceutical, method for manufacturing same, and application thereof
#87Preparation of a 1-amino-3-hydroxy-cyclobutane-1-carboxylic acid derivative
#88Eluent solution
#89Fluorinated 2-amino-4-(benzylamino)phenylcarbamate derivatives
#90Imaging agents
#91Compositions, methods, and systems for the synthesis and use of imaging agents
#92METHOD FOR PRODUCTION OF F-18 LABELED GLUTAMIC ACID DERIVATIVES
#93IN VIVO IMAGING AGENTS
#94Labeled molecular imaging agents and methods of use
#95METHOD OF RADIOTHERAPY USING A RADIOLABELLED RGD PEPTIDE
#96N-alkoxyamide conjugates as imaging agents
#97Method for production of radiation diagnostic imaging agent
#98Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
#99Methods and compositions for F-18 labeling of proteins, peptides and molecules
#100Cancer-imaging agent and method of radioimaging using the same
#101Anti-mucin antibodies for early detection and treatment of pancreatic cancer
#102Methods and compositions for improved F labeling of proteins, peptides and other molecules
#103Liver-receptor imaging injection, dispensing method and pharmaceutical composition thereof
#104Mitochondrial inhibitors to treat human disease
#105In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agents
#106Radioactively Labeled Substance
#107Molecular imaging agents
#108RADIOIODINATION METHOD
#109Methods and compositions for F-18 labeling of proteins, peptides and other molecules
#110Detection of early-stage pancreatic adenocarcinoma
#111Imaging agents
#112IN VIVO IMAGING AGENTS
#113Reactivation of axon growth and recovery in chronic spinal cord injury
#114Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
#115Carbon-11 and fluorine-18 labeled radioligands for positron emission tomography (PET) imaging for the brain serotonin transporters
#116Radiometal-labeled amino acid analogs, imaging and therapeutic agents incorporating the same, and methods using the same
#117Labeled inhibitors of prostate specific membrane antigen (PSMA), biological evaluation, and use as imaging agents
#118Imaging Agents
#119PREPARATION OF RADIOLABELLED HALOAROMATICS VIA POLYMER-BOUND INTERMEDIATES
#120Labeled molecular imaging agents, methods of making and methods of use
#121Cyclodextrin compound modified with folic acid, process for production thereof, drug delivery agent for targeting drug delivery system, pharmaceutical composition, and imaging agent
#122Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof
#123Method for production of radiation diagnostic imaging agent
#124Detection and quantification of abasic site formation in vivo
#125Imaging agents useful for identifying AD pathology
#126Methods of radiofluorination of biologically active vectors
#127RADIOACTIVE DIAGNOSTIC IMAGING AGENT
#128Radioactive diagnostic imaging agent
#129Process for production of precursor compound for radioactive halogen-labeled organic compound
#130Anti-pancreatic cancer antibodies
#131Methods and compositions for F-18 labeling of proteins, peptides and other molecules
#132Method for the use of [C] carbon monoxide in labeling synthesis of C-labelled amides using metal amides and photo-induced free radical carbonylation
#133Mixtures Of Calcitonin Drug-Oligomer Conjugates And Methods Of Use In Pain Treatment
#134NECROSIS AVID TRACER AGENT
#135Methods and compositions for F-18 labeling of proteins, peptides and other molecules
#136Inhibitors of carbonic anhydrase IX
#137In vivo imaging compounds
#138Methods and compositions for F-18 labeling of proteins, peptides and other molecules
#139Method for imaging and treating organs and tissues
#140DIAGNOSTIC AGENTS FOR POSITRON EMISSION IMAGING USING F-18 RADIO-LABELED AMINO-ALCOHOLS
#141Organic compound and method for producing radioactive halogen-labeled organic compound using the same
#142Diagnosis of infection in the lungs of patients
#143Compounds, compositions and methods for medical imaging of Parkinson's disease
#144Unnatural amino acid radiolabeling precursor
#145Methods and compositions for F-18 labeling of proteins, peptides and other molecules
#146Combination set of Meta-Iodobenzyl guanidine freezing crystal and making method thereof and method for making a radioactive iodine marker
#147Novel Differential Imaging Method
#148Radiolabeled selective androgen receptor modulators and their use in prostate cancer imaging and therapy
#149PREPARATION AND METHOD UTILIZING RADIOLABELED CHLOROTOXIN
#150Preparation of radiolabelled haloaromatics via polymer-bound intermediates
#151Method of deprotection
#152Methods and compounds for detection of medical disorders
#153Fluoride carrier for positron emission tomography
#154Mixtures Of Calcitonin Drug-Oligomer Conjugates And Methods Of Use In Pain Treatment
#155Contrast medium for thrombus formation
#156Copper-complex isonitrile positron emission tomography (pet) imaging agent and method
#157Photoreactive compounds and compositions
#158Necrosis avid tracer agent
#159Imaging agents
#160F-18 Labeled Amino Acid Analogs
#161Radioligands for the TRP-M8 receptor and methods therewith
#162Labeled macrophage scavenger receptor antagonists for imaging cardiovascular diseases
#163RI-labeled compound synthesizing system
#164Method for the use of [C] carbon monoxide in labeling synthesis of C-labelled amides using metal amides and photo-induced free radical carbonylation
#165Imaging agents
#166Radioactively labelled amino acid analogues, their preparation and use
#167Radiolabeled cannabinoid-1 receptor modulators
#168Solid phase preparation of F-labelled amino acids
#169Radioligands for the TRP-M8 receptor and methods therewith
#170Method of evaluating pharmacological effects of medicine
#171Novel compounds useful in pain management